Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema
NCT01326910 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2012-08-03
Summary
This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.
Conditions
Interventions
- DRUG
-
Colloidal Oatmeal
Topical cream applied twice daily (or as needed)
- DEVICE
-
Topical Cream
Topical cream applied twice daily (or as needed)
Sponsors & Collaborators
-
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
lead INDUSTRY
Principal Investigators
-
Qing Li, MD, PhD · Johnson & Johnson Consumer and Personal Products Worldwide
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children
NCT04740892 ·Status: COMPLETED ·Phase: NA
-
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381 ·Status: UNKNOWN
-
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
NCT07146971 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
NCT00828412 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis
NCT01174511 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
NCT02732314 ·Status: COMPLETED ·Phase: PHASE4
-
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters
NCT07056569 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis
NCT01079897 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
CT 327 in the Treatment of Atopic Dermatitis
NCT00996008 ·Status: TERMINATED ·Phase: PHASE2
-
A Community-based Assessment of Skin Care, Allergies, and Eczema
NCT03409367 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
NCT03091426 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
NCT01602341 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis
NCT02118766 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
NCT00919763 ·Status: COMPLETED ·Phase: PHASE2
-
Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product
NCT02615561 ·Status: COMPLETED ·Phase: NA
-
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
NCT02949960 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Emollient Therapy on the Skin Barrier
NCT01291940 ·Status: COMPLETED ·Phase: NA
-
A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
NCT05226143 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
NCT04307862 ·Status: UNKNOWN ·Phase: PHASE2
-
Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
NCT02289989 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis
NCT02118792 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Emollient on Xerosis in Children With Atopic Dermatitis
NCT01467362 ·Status: COMPLETED ·Phase: PHASE3